[ Price : $8.95]
FDA accepts for review a Biohaven Pharmaceutical Holding Co. 505(b)(2) NDA for BHV-0223, an investigational sublingual form of ril...[ Price : $8.95]
FDA classifies as Class 1 an Oscor recall of its TB Temporary Bipolar Pacing Leads due to connector separation that may cause a lo...[ Price : $8.95]
FDA issues a Form FDA-483 after an August inspection of a Cantrell Drug Co. outsourcing facility in Little Rock, AR.[ Price : $8.95]
FDA approves Genentechs ACTPen 162 mg/0.9 mL, a single-dose prefilled autoinjector for Actemra (tocilizumab) as an additional form...[ Price : $8.95]
FDA Review posts the Federal Register notices for the week ending 11/23/2018.[ Price : $8.95]
Four stakeholders comment on an FDA report on the servicing of medical devices.[ Price : $8.95]
AdvaMed submits line-by-line comments to FDA on a draft guidance on considering uncertainty in medical device benefit-risk determi...[ Price : $8.95]
Federal Register notice: FDA announces an approval for Tevas Ajovy (fremanezumab-vfrm) injection for preventing migraine in adults...